NEUROGENESIS BIO RECEIVES FDA CLEARANCE TO PROCEED WITH EXPANDED ACCESS PROGRAM FOR NG01 IN PROGRESSIVE MULTIPLE SCLEROSIS

Reuters · 1d ago

Please log in to view news